Associate Consultant-Customer Engagement

Beghou names Meredith Ressi as President and Chief Growth Officer. By GlobeNewswire February 3, 2026 Appointment reflects Beghou's focus on scaling intelligently with integrated teams and technology to support clients throughout their commercialization journey EVANSTON, Ill., Feb. 03, 2026 (GLOBE NEWSWIRE) - Beghou, a leading provider of data, analytics, and technology solutions for life sciences commercialization, today announced that Chief Growth Officer Meredith Ressi has been named President and Chief Growth Officer. In this expanded role, she will deepen Beghou's commitment to client experience excellence across every touchpoint, from go-to-market through solution delivery and long-term partnerships. Meredith will also ensure that Beghou's unique combination of people, processes, and technology is optimized to deliver success across diverse client challenges. "It has been my absolute pleasure to work alongside Meredith and learn from her insights and experience here at Beghou," said Adrienne Lovink, Chief Executive Officer at Beghou. "Now, in this expanded role, she'll ensure that we continue to scale intelligently and with purpose so that clients always have access to the right people and technology to achieve their goals. I am Meredith's biggest fan and am thrilled to partner with her as we broaden our impact within the industry and continue to help bring life-changing therapies to providers and patients." Meredith is a highly regarded industry leader with more than two decades of experience driving growth at digital health and life sciences companies. She has a proven track record of building innovative solutions and high-performing teams that help clients connect more deeply with their customers and improve how therapies reach and serve patients. Meredith developed and led one of the industry's first digital health programs early in her career and has since worked closely with pharmaceutical companies to craft and execute strategic development and innovation plans as a C-suite leader at Integrated Wellness Solutions, Decision Resources Group, Clarivate, and ClearSight Health. About Beghou Beghou drives commercialization that works for life sciences. For over 30 years, Beghou has been a long-term consulting and technology partner to more than 200 life sciences clients. We connect the dots between strategy, data, technology, and teams - helping clients accelerate launches, deepen customer engagement, and advance patient access. Whether a company is pre-commercial building from scratch or in-market and refining its strategy, Beghou provides fresh ideas and pragmatic, tech-enabled solutions to help them adapt and thrive in increasing complexity. We build enduring partnerships by remaining engaged and accountable far beyond project delivery to ensure solutions take hold and work. We achieve faster results and lasting impact using the right mix of strategic thinking, technical expertise, and hands-on collaboration and execution. Once you've worked with Beghou, you'll have an ally at every step of your career. Find out why at Beghou.com. Media Contact: Michael Azzano Cosmo PR for Beghou powered by 415-596-1978

Beghou adds new partners to advance integrated, experience-driven commercialization in life sciences. Beghou today announced that seasoned industry leaders Jenny Herritz and Marcos Mendell have joined as partners. This reflects Beghou's commitment to hiring top talent and its focus on helping life sciences companies build more connected, effective commercialization engines that translate strategies into measurable results and cohesive experiences for providers, patients, and payers. With prior roles at Real Chemistry, Pfizer, SVA Companies, and more, the new partners bring deep experience across both emerging and established biopharma - strengthening Beghou's ability to transfer learnings across the commercialization lifecycle, from first launches to enterprise transformation. At Beghou, they will ensure that commercialization efforts are anchored in data, experience design, and operational excellence. "Clients value our ability to zoom out to assess the bigger picture and provide fresh ideas amidst all the data and disruption in the market today. The key is finding incredible people like Jenny and Marcos who have expertise in critical, in-demand areas, and who exemplify the collaborative, hands-on way of working that our clients love," said Adrienne Lovink, CEO at Beghou. "I'm excited to see them dig in alongside the rest of the team at Beghou, connecting strategy with data so our clients can deliver more meaningful experiences and impact for their customers." About the new partners Jenny Herritz specializes in helping emerging life sciences companies create the foundation for a successful first-time product launch that can scale as they grow. With more than 24 years of experience, she has guided organizations through commercial readiness and infrastructure design across rare disease, oncology, and specialty therapeutics. Most recently, she served as Principal at SVA Consulting, co-leading its life sciences vertical. Jenny holds a BBA in Management Information Systems from the University of Wisconsin-Eau Claire and is a Harvard Business School alumna. Marcos Mendell brings more than two decades of expertise in shaping the future of healthcare engagement through experience design and advanced data analytics. Known for transforming how pharmaceutical companies connect with providers and patients, he integrates medical, commercial, field, and patient touchpoints into unified, personalized experiences. He previously led Enterprise Experience and Business Strategy at Real Chemistry and spent over ten years at Pfizer, culminating as U.S. Lead for Business Intelligence. Marcos holds a BBA in Marketing Management from Baruch College and executive credentials from MIT.